Tedizolid

Trade Name: 
Sivextro
Manufacturer/Distributor: 
Merck Canada
Classification: 
Oxazolidinone antibiotic
ATC Class: 
J01XX - other antibacterials
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2015/09/29
Date Marketed in Canada (yyyy/mm/dd): 
2015/10/08
Presentation: 
Tablet: 200 mg. DIN: 02438623
Injection: 200 mg/vial. DIN: 02438631
Comments: 
For the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible strains of the following gram-positive microorganisms in adults 18 years of age and older: Staphylococcus aureus (including methicillin-resistant [MRSA]), Streptococcus pyogenes, Streptococcus agalactiae, and Streptococcus anginosus Group (including Streptococcus anginosus, Streptococcus intermedius, and Streptococcus constellatus).